Eberhard Karls Universität Tübingen

University / College


Location: Tübingen, Germany (DE) DE

ISNI: 0000000121901447

ROR: https://ror.org/03a1kwz48

Show on Map:


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

A Warm Welcome to MedChem: The Frontiers in Medicinal Chemistry 2025 (2025) Schiedel M, Pinto M, Unzue Lopez A, Barbie P, Pape F, Tarasewicz A, Hessler G, et al. Journal article Hazard rates and implications for follow-up schedules of melanoma patients with 0.8–1.0 mm tumor thickness: An analysis of the German Central Malignant Melanoma Registry in 12,132 patients (2025) Aebischer V, Nanz L, Amaral T, Berking C, Eigentler T, Flatz L, Forschner A, et al. Journal article A Hitchhiker's Guide to Translation-Ideas for Fostering and Disseminating (Clinical) Translational Psychology (2025) Berg M, Suchotzki K, Zimmermann J, Merz CJ, Szota K, Brandt H, Hartwigsen G, et al. Journal article, Review article Efficacy and tolerability of fenfluramine with concomitant potassium bromide in patients with Dravet syndrome (2025) Pringsheim M, Kluger G, Strzelczyk A, Schubert-Bast S, Mayer T, Glauche B, Muhle H, et al. Journal article Rache (2025) Teuchert L Other publication type Androgenrezeptor-gerichtete Therapien – klinisch relevante Interaktionen vermeiden (2025) Lipp HP, Von Amsberg G, Merseburger AS, Rausch S, Schöning T, Klier J, Goebell P Journal article, Review article DAPHNE4NFDI - Improving Research data management at Synchrotron Facilities (2025) Amelung L, Barty A, Murphy BM, Grunwaldt JD, Hövelmann S, Leonau A, Paripsa S, et al. Conference contribution Increasing motivation and well-being among medical students using curricular self-experience group sessions—a randomized controlled trial (2025) Spitzer P, Mittmann C, Utz J, Mestermann S, Festl-Wietek T, Kornhuber J, Herrmann-Werner A Journal article Prospective randomized phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer - results of the SUNNIFORECAST trial (2025) Bergmann L, Albiges L, Ahrens M, Gross-Goupil M, Boleti E, Gravis G, Fléchon A, et al. Journal article Heterogeneously Catalyzed Energy Release in Azaborinine-based Molecular Solar Thermal Systems (2025) Hussain Z, Einholz R, Biebl SM, Franz E, Müller A, Dreuw A, Bettinger HF, et al. Journal article